Table 1.
Clinical characteristics of patients (n = 16)
| Male | 11 (68.8%) |
| Median age, years (IQR) | 55 (40.5–71.5) |
| Median duration from onset of symptoms to hospitalization, days (IQR) | 7 (3.25–9) |
| Underlying disease | |
| Diabetes mellitus | 4 (25%) |
| Hypertension | 2 (12.5%) |
| Heart disease | 2 (12.5%) |
| Treatment | |
| Azithromycin | 11 (68.8%) |
| Favipiravir | 11 (68.8%) |
| Nafamostat | 12 (75%) |
| Tocilizumab | 7 (43.7%) |
| Disease severity | |
| Mild | 6 (37.5%) |
| Severe | 10 (62.5%) |
| PaO2/FiO2 ratio | |
| > 350 | 6 (37.5%) |
| 200–300 | 5 (31.25%) |
| 150–200 | 3 (18.75%) |
| < 150 | 2 (12.5%) |
IQR interquartile range, PaO2/FiO2ratio ratio of arterial partial pressure of oxygen to the fraction of inspired oxygen